Bozlu Holding

Bozlu Holding is a Turkey-based private holding company with major operations in healthcare, particularly nuclear medicine, radiation oncology, medical technology, and related pharmaceutical activities. The group was built around MNT, a long-standing provider of nuclear medicine and radiation oncology services, and it positions itself as a developer of healthcare value chains in Turkey and other regional markets. Bozlu appears to operate primarily as a commercial healthcare services and distribution group rather than a drug-development biotech, with activities spanning diagnostic and therapeutic nuclear medicine, oncology infrastructure, and broader industrial businesses. In 2026, the group announced an exclusive regional distribution agreement with TAE Life Sciences for the Alphabeam boron neutron capture therapy platform and associated boron drug candidates across Turkiye, Eastern Europe, and Central Asia. Overall, Bozlu is best characterized as an active healthcare-focused conglomerate with commercial operations in oncology, nuclear medicine, and advanced health technologies.